These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 16084851

  • 1. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M, Yano I, Masuda S, Fukatsu S, Katsura T, Ogura Y, Oike F, Takada Y, Tanaka K, Inui K.
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [Abstract] [Full Text] [Related]

  • 2. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF, Stolpman N, Wachs M, Bak T, Kugelmas M, Kam I, Everson GT.
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [Abstract] [Full Text] [Related]

  • 3. [Therapeutic monitoring of immunosuppressive drugs: interest of calcineurin activity assessment in liver transplantation].
    Blanchet B.
    Ann Pharm Fr; 2008 Mar; 66(2):96-101. PubMed ID: 18570908
    [Abstract] [Full Text] [Related]

  • 4. Suitable calcineurin inhibitor concentrations for liver transplant recipients in the Chinese population.
    Chen YB, Li SD, Ju BL, Shi XJ, Lu F, Hu DK, Yu CH, Dong JH.
    Transplant Proc; 2011 Jun; 43(5):1751-3. PubMed ID: 21693271
    [Abstract] [Full Text] [Related]

  • 5. A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection.
    Fukudo M, Yano I, Katsura T, Ito N, Yamamoto S, Kamoto T, Ogawa O, Inui K.
    Drug Metab Pharmacokinet; 2010 Jun; 25(5):411-7. PubMed ID: 20834189
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G, Grazi GL, Sanjuan F, Wu Y, Mühlbacher F, Samuel D, Friman S, Jones R, Cantisani G, Villamil F, Cillo U, Clavien PA, Klintmalm G, Otto G, Pollard S, McCormick PA.
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [Abstract] [Full Text] [Related]

  • 8. Intracellular ATP production in CD4+ T cells as a predictor for infection and allograft rejection in trough-level guided pediatric liver transplant recipients under calcineurin-inhibitor therapy.
    Schulz-Juergensen S, Burdelski MM, Oellerich M, Brandhorst G.
    Ther Drug Monit; 2012 Feb; 34(1):4-10. PubMed ID: 22210096
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Elevated blood concentrations of calcineurin inhibitors during diarrheal episode in pediatric liver transplant recipients: involvement of the suppression of intestinal cytochrome P450 3A and P-glycoprotein.
    Maezono S, Sugimoto K, Sakamoto K, Ohmori M, Hishikawa S, Mizuta K, Kawarasaki H, Watanabe Y, Fujimura A.
    Pediatr Transplant; 2005 Jun; 9(3):315-23. PubMed ID: 15910387
    [Abstract] [Full Text] [Related]

  • 11. Suppressive potencies of calcineurin inhibitors against the mitogen-induced blastogenesis of peripheral-blood mononuclear cells of myasthenia gravis patients.
    Tanaka S, Nakajima K, Hirano T, Oka K, Saito T, Wakata N.
    J Pharm Pharmacol; 2008 Oct; 60(10):1341-6. PubMed ID: 18812027
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the temporal profile of calcineurin inhibition by cyclosporine and tacrolimus in renal transplant patients.
    Koefoed-Nielsen PB, Karamperis N, Jørgensen KA.
    Transplant Proc; 2005 May; 37(4):1736-8. PubMed ID: 15919449
    [Abstract] [Full Text] [Related]

  • 13. Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation.
    Goto M, Masuda S, Kiuchi T, Ogura Y, Oike F, Tanaka K, Uemoto S, Inui K.
    J Pharmacol Exp Ther; 2008 May; 325(2):610-6. PubMed ID: 18252812
    [Abstract] [Full Text] [Related]

  • 14. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation.
    Staatz CE, Taylor PJ, Lynch SV, Tett SE.
    Liver Transpl; 2004 Apr; 10(4):506-12. PubMed ID: 15048793
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.
    Blanchet B, Duvoux C, Costentin CE, Barrault C, Ghaleh B, Salvat A, Jouault H, Astier A, Tod M, Hulin A.
    Ther Drug Monit; 2008 Aug; 30(4):412-8. PubMed ID: 18641556
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.
    Jain A, Venkataramanan R, Sharma R, Kwong T, Orloff M, Abt P, Kashyap R, Tsoulfas G, Batzold P, Williamson M, Bozorgzadeh A.
    Transplantation; 2008 Feb 27; 85(4):554-60. PubMed ID: 18347534
    [Abstract] [Full Text] [Related]

  • 18. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring.
    Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP.
    Transplant Proc; 2009 Mar 27; 41(2):707-9. PubMed ID: 19328963
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion.
    Cantarovich M, Barkun J, Giannetti N, Cecere R, Besner JG, Tchervenkov J.
    Transplant Proc; 2004 Mar 27; 36(2 Suppl):442S-447S. PubMed ID: 15041383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.